| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |